| Humoral responses and serological assays in SARS-CoV-2 infections Y Galipeau, M Greig, G Liu, M Driedger, MA Langlois Frontiers in immunology 11, 610688, 2020 | 280 | 2020 |
| A scalable serology solution for profiling humoral immune responses to SARS‐CoV‐2 infection and vaccination K Colwill, Y Galipeau, M Stuible, C Gervais, C Arnold, B Rathod, KT Abe, ... Clinical & translational immunology 11 (3), e1380, 2022 | 108 | 2022 |
| Relative ratios of human seasonal coronavirus antibodies predict the efficiency of cross-neutralization of SARS-CoV-2 spike binding to ACE2 Y Galipeau, V Siragam, G Laroche, E Marion, M Greig, M McGuinty, ... EBioMedicine 74, 2021 | 58 | 2021 |
| Platelet activation by SARS-CoV-2 implicates the release of active tissue factor by infected cells F Puhm, I Allaeys, E Lacasse, I Dubuc, Y Galipeau, Y Zaid, L Khalki, ... Blood Advances 6 (12), 3593-3605, 2022 | 49 | 2022 |
| Dried blood spot specimens for SARS-CoV-2 antibody testing: A multi-site, multi-assay comparison F Cholette, C Mesa, A Harris, H Ellis, K Cachero, P Lacap, Y Galipeau, ... PloS one 16 (12), e0261003, 2021 | 44 | 2021 |
| COVID-19 vaccine immunogenicity in people with HIV CT Costiniuk, J Singer, T Lee, MA Langlois, C Arnold, Y Galipeau, ... Aids 37 (1), F1-F10, 2023 | 29 | 2023 |
| Household transmission of SARS-CoV-2 from unvaccinated asymptomatic and symptomatic household members with confirmed SARS-CoV-2 infection: an antibody-surveillance study M Bhatt, AC Plint, K Tang, R Malley, AP Huy, C McGahern, J Dawson, ... Canadian Medical Association Open Access Journal 10 (2), E357-E366, 2022 | 29 | 2022 |
| Homogeneous surrogate virus neutralization assay to rapidly assess neutralization activity of anti-SARS-CoV-2 antibodies SJ Kim, Z Yao, MC Marsh, DM Eckert, MS Kay, A Lyakisheva, M Pasic, ... Nature communications 13 (1), 3716, 2022 | 24 | 2022 |
| Seasonal respiratory virus circulation was diminished during the COVID‐19 pandemic A Heiskanen, Y Galipeau, J Little, L Mortimer, K Ramotar, MA Langlois, ... Influenza and Other Respiratory Viruses 17 (1), e13065, 2023 | 14 | 2023 |
| Cohort profile: Stop the Spread Ottawa (SSO)—A community-based prospective cohort study on antibody responses, antibody neutralisation efficiency and cellular immunity to SARS … E Collins, Y Galipeau, C Arnold, C Bosveld, A Heiskanen, A Keeshan, ... BMJ open 12 (9), e062187, 2022 | 14 | 2022 |
| Comparative performance data for multiplex SARS-CoV-2 serological assays from a large panel of dried blood spot specimens F Cholette, R Fabia, A Harris, H Ellis, K Cachero, L Schroeder, C Mesa, ... Heliyon 8 (9), 2022 | 14 | 2022 |
| Characterization of systemic and mucosal humoral immune responses to an adjuvanted intranasal SARS-CoV-2 protein subunit vaccine candidate in mice M Maltseva, Y Galipeau, TM Renner, L Deschatelets, Y Durocher, ... Vaccines 11 (1), 30, 2022 | 9 | 2022 |
| Scalable agroinfiltration-based production of SARS-CoV-2 antigens for use in diagnostic assays and subunit vaccines J Demone, M Maltseva, M Nourimand, M Nasr-Sharif, Y Galipeau, ... Plos one 17 (12), e0277668, 2022 | 9 | 2022 |
| Antibody seronegativity in COVID-19 RT-PCR–positive children M Bhatt, RL Zemek, K Tang, R Malley, AC Plint, A Pham-Huy, J Dawson, ... The Pediatric infectious disease journal 41 (8), e318-e320, 2022 | 8 | 2022 |
| A scalable serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccination. Clin Transl Immunol. 2022; 11: e1380 K Colwill, Y Galipeau, M Stuible, C Gervais, C Arnold, B Rathod, KT Abe, ... | 8 | |
| Results of the Stop the Spread Ottawa (SSO) cohort study: a Canadian urban-based prospective evaluation of antibody responses and neutralisation efficiency to SARS-CoV-2 … A Keeshan, Y Galipeau, A Heiskanen, E Collins, PS McCluskie, C Arnold, ... BMJ open 13 (10), e077714, 2023 | 6 | 2023 |
| The effect of dose-interval on antibody response to mRNA COVID-19 vaccines: a prospective cohort study ND Almeida, I Schiller, D Ke, E Sakr, M Plesa, S Vanamala, AL Moneger, ... Frontiers in Immunology 15, 1330549, 2024 | 5 | 2024 |
| Longitudinal profiles of plasma gelsolin, cytokines and antibody expression predict COVID-19 severity and hospitalization outcomes M Asare-Werehene, M McGuinty, A Vranjkovic, Y Galipeau, J Cowan, ... Frontiers in Immunology 13, 1011084, 2022 | 5 | 2022 |
| Antibody neutralization capacity after coronavirus disease 2019 vaccination in people with HIV in Canada CT Costiniuk, J Singer, T Lee, Y Galipeau, PS McCluskie, C Arnold, ... AIDS 37 (12), F25-F35, 2023 | 4 | 2023 |
| Seasonal human coronaviruses OC43, 229E, and NL63 induce cell surface modulation of entry receptors and display host cell-specific viral replication kinetics V Siragam, M Maltseva, N Castonguay, Y Galipeau, MM Srinivasan, ... Microbiology Spectrum 12 (7), e04220-23, 2024 | 3 | 2024 |
